Urologists face a dilemma when a lesion identified on multiparametric magnetic resonance imaging is benign on image guided fusion biopsy.
Two studies confirm with a much larger patient population and longer follow-up that CyberKnife stereotactic body radiotherapy (SBRT), from Accuray,...
The Cyberknife VSI system, from Accuray Inc., has been utilised in a new treatment method, stereotactic body radiotherapy (SBRT), which...
St. Jude Medical, Inc. announced FDA approval for full-body magnetic resonance (MR) Conditional labeling for the Proclaim Elite Spinal Cord...
Medtronic plc is the first company to receive FDA approval for its suite of cardiac rhythm and heart failure devices...
Siemens Healthineers announced it has secured FDA clearance for its Magnetom Vida 3 Tesla magnetic resonance imaging system. The company...
Background: Advances in radiation technology have transformed treatment options for patients with localized prostate cancer. The evolution of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy...
The American Society for Radiation Oncology (ASTRO) produced an evidence-based guideline on treatment with stereotactic body radiotherapy (SBRT) for patients with early-stage non–small-cell lung cancer.
Purpose of review: The aim of this article is to review the role of prostate radiotherapy in the multimodal management of newly diagnosed metastatic hormone naïve prostate cancer.